DOXGX | EICVX | DOXGX / EICVX | |
Total Expense Ratio | 0.41 | 1.21 | 34% |
Annual Report Gross Expense Ratio | 0.46 | 1.25 | 37% |
Fund Existence | 3 years | 14 years | - |
Gain YTD | 7.150 | 10.761 | 66% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 117B | 341M | 34,311% |
Annual Yield % from dividends | 1.47 | 1.84 | 80% |
Returns for 1 year | 7.74 | 11.05 | 70% |
Returns for 3 years | 30.82 | 27.38 | 113% |
Returns for 5 years | N/A | 68.85 | - |
Returns for 10 years | N/A | 56.70 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GSLIX | 16.70 | N/A | N/A |
Goldman Sachs Large Cap Value Instl | |||
PMFMX | 23.11 | N/A | N/A |
Principal MidCap S&P 400 Index R3 | |||
VTSNX | 148.36 | N/A | N/A |
Vanguard Total Intl Stock Index I | |||
JFNCX | 54.93 | N/A | N/A |
Janus Henderson Global Life Sciences C | |||
CBGAX | 14.28 | N/A | N/A |
ClearBridge Global Infrastructure Inc C |